Chronic wet cough: Protracted bronchitis, chronic suppurative lung disease and bronchiectasis

Pediatric Pulmonology

Volumn 43, Issue 6, 2008, Pages 519-531

  Chang, A B ^a,b   Redding, G J ^c,d   Everard, M L ^e  

^a MENZIES SCHOOL OF HEALTH RESEARCH   (Australia)

^b ROYAL CHILDREN'S HOSPITAL   (Australia)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^d Regional Medical Center   (United States)

^e SHEFFIELD CHILDREN S HOSPITAL   (United Kingdom)

Author keywords

Asthma; Bronchiectasis; Cough

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BROMHEXINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; INDOMETACIN; LEUKOTRIENE RECEPTOR BLOCKING AGENT; MACROLIDE; MUCOLYTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; OXYGEN; PNEUMOCOCCUS VACCINE; TOBRAMYCIN;

ACUPUNCTURE; ASTHMA; BACTERIAL COLONIZATION; BREATHING EXERCISE; BRONCHIECTASIS; BRONCHITIS; CHRONIC DISEASE; CHRONIC LUNG DISEASE; CLINICAL FEATURE; CLINICAL TRIAL; COUGHING; DIAGNOSTIC ERROR; DISEASE ASSOCIATION; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; LUNG SURGERY; MUCOCILIARY CLEARANCE; NONHUMAN; OXYGEN THERAPY; PATHOGENESIS; PRIORITY JOURNAL; QUALITY OF LIFE; RESPIRATORY TRACT INFECTION; REVIEW; RISK FACTOR;

ANTI-BACTERIAL AGENTS; ASTHMA; BRONCHIECTASIS; BRONCHITIS; CHILD; CHRONIC DISEASE; COUGH; DIAGNOSIS, DIFFERENTIAL; HUMANS; SUPPURATION; TREATMENT OUTCOME;

EID: 44949238028     PISSN: 87556863     EISSN: 10990496     Source Type: Journal    
DOI: 10.1002/ppul.20821     Document Type: Review

References (141)

1. Irwin RS. Introduction to the diagnosis and management of cough: ACCP Evidence-Based Clinical Practice Guidelines. Chest 2006;129:25S-27S.
2. Britt H, Miller GC, Knox S, Charles J, Valenti L, Henderson J, Pan Y, Sutton S, Harrison C. Bettering the Evaluation and Care of Health - A Study of General Practice Activity. Australian Institute of Health and Welfare 2002; AIHW Cat. No. GEP-10.
3. Britt H, Miller GC, Knox S, Charles J, Valenti L, Pan Y, Henderson J, et al. General Practice Activity in Australia 2003-2004. Australian Institute of Health and Welfare 2004; AIHW Cat No GEP 16.
4. Chang AB, Glomb WB. Guidelines for evaluating chronic cough in pediatrics: ACCP Evidence-Based Clinical Practice Guidelines. Chest 2006;129:260S-283S.
5. Chang AB, Landau LI, van Asperen PP, Glasgow NJ, Robertson CF, Marchant JM, Mellis CM. The Thoracic Society of Australia and New Zealand. Position statement. Cough in children: definitions and clinical evaluation. Med J Aust 2006;184:398-403.
6. Faniran AO, Peat JK, Woolcock AJ. Persistent cough: is it asthma? Arch Dis Child 1998;79:411-414.
7. Cornford CS, Morgan M, Ridsdale L. Why do mothers consult when their children cough? Fam Pract 1993;10:193-196.
8. Newcombe PA, Sheffield JK, Juniper EF, Halstead RA, Masters IB, Chang AB. Development of a parent-proxy cough-specific QOL questionnaire: clinical impact vs psychometric evaluations. Chest 2008;133:386-395.
9. Karakoc F, Karadag B, Akbenlioglu C, Ersu R, Yildizeli B, Yuksel M, Dagli E. Foreign body aspiration: what is the outcome? Pediatr Pulmonol 2002;34:30-36.
10. Gupta A, McKean M, Chang AB. Management of chronic non-specific cough in childhood: an evidence-based review. Arch Dis Child Educ Pract Ed 2007;92:33-39.
11. Shields MD, Bush A, Everard ML, McKenzie SA, Primhak R. British Thoracic Society Guidelines Recommendations for the assessment and management of cough in children. Thorax 2008;63:iii1-iii15.
12. Kusel MM, de KN, Holt PG, Landau LI, Sly PD. Occurrence and management of acute respiratory illnesses in early childhood. J Paediatr Child Health 2007;43:139-146.
13. Masters IB, Zimmerman PV, Pandeya N, Petsky HL, Wilson SB, Chang AB. Quantified tracheobronchomalacia disorders and their clinical profiles in children. Chest 2008;133:461-467.
14. Korpas J, Sadlonova J, Salat D, Masarova E. The origin of cough sounds. Bull Eur Physiopathol Respir 1987;23:47s-50s.
15. Hashimoto Y, Murata A, Mikami M, Nakamura S, Yamanaka E, Kudoh S. Influence of the rheological properties of airway mucus on cough sound generation. Respirology 2003;8:45-51.
16. Murata A, Taniguchi Y, Hashimoto Y, Kaneko Y, Takasaki Y, Kudoh S. Discrimination of productive and non-productive cough by sound analysis. Intern Med 1998;37:732-735.
17. Chang AB, Masel JP, Boyce NC, Wheaton G, Torzillo PJ. Non-CF bronchiectasis-clinical and HRCT evaluation. Pediatr Pulmonol 2003;35:477-483.
18. Nunn JF. Non-elastic resistance to gas flow. Applied Respiratory Physiology London: Butterworths, 1993.
19. Korpas J, Widdicombe JG, Vrabec M. Influence of simulated mucus on cough sounds in cats. Respir Med 1993;87:49-54.
20. Chang AB, Eastburn MM, Gaffney J, Faoagali J, Cox NC, Masters IB. Cough quality in children: a comparison of subjective vs. bronchoscopic findings. Respir Res 2005;6:3.
21. Elphick HE, Sherlock P, Foxall G, Simpson EJ, Shiell NA, Primhak RA, Everard ML. Survey of respiratory sounds in infants. Arch Dis Child 2001;84:35-39.
22. Cane RS, McKenzie SA. Parents' interpretations of children's respiratory symptoms on video. Arch Dis Child 2001;84:31-34.
23. Cane RS, Ranganathan SC, McKenzie SA. What do parents of wheezy children understand by "wheeze"? Arch Dis Child 2000;82:327-332.
24. Foster WM. Mucus secretion and cough. In: Chung KF, Widdicombe JG, Boushey HA, editors. Cough: causes, mechanisms and therapy. London: Blackwell Science; 2003;207-216.
25. Irwin RS, Baumann MH, Bolser DC, Boulet LP, Braman SS, Brightling CE, Brown KK, et al. Diagnosis and management of cough executive summary: ACCP Evidence-Based Clinical Practice Guidelines. Chest 2006;129:1S-23S.
26. Nikolaizik WH, Warner JO. Aetiology of chronic suppurative lung disease. Arch Dis Child 1994;70:141-142.
27. Saynajakangas O, Keistinen T, Tuuponen T, Kivela SL. Bronchiectasis in Finland: trends in hospital treatment. Respir Med 1997;91:395-398.
28. Karakoc GB, Yilmaz M, Altintas DU, Kendirli SG. Bronchiectasis: still a problem. Pediatr Pulmonol 2001;32:175-178.
29. Callahan CW, Redding GJ. Bronchiectasis in children: orphan disease or persistent problem? Pediatr Pulmonol 2002;33:492-496.
30. Sethi GR, Batra V. Bronchiectasis: causes and management. Indian J Pediatr 2000;67:133-139.
31. Karadag B, Karakoc F, Ersu R, Kut A, Bakac S, Dagli E. Non-cystic-fibrosis bronchiectasis in children: a persisting problem in developing countries. Respiration 2005;72:233-238.
32. Singleton RJ, Morris A, Redding G, Poll J, Hoick P, Martinez P, Kruse D, et al. Bronchiectasis in Alaska Native children: causes and clinical courses. Pediatr Pulmonol 2000;29:182-187.
33. Edwards EA, Metcalfe R, Milne DG, Thompson J, Byrnes CA. Retrospective review of children presenting with non cystic fibrosis bronchiectasis: HRCT features and clinical relationships. Pediatr Pulmonol 2003;36:87-93.
34. Chang AB, Grimwood K, Mulholland EK, Torzillo PJ. Bronchiectasis in Indigenous children in remote Australian communities. A position statement. Med J Aust 2002;177:200-204.
35. Keistinen T, Saynajakangas O, Tuuponen T, Kivela SL. Bronchiectasis: an orphan disease with a poorly-understood prognosis. Eur Respir J 1997;10:2784-2787.
36. Martinez-Garcia MA, Perpina-Tordera M, Roman-Sanchez P, Soler-Cataluna JJ. Quality-of-life determinants in patients with clinically stable bronchiectasis. Chest 2005;128:739-745.
37. Nicotra MB, Rivera M, Dale AM, Shepherd R, Carter R. Clinical, pathophysiologic, and microbiologic characterization of bronchiectasis in an aging cohort. Chest 1995;108:955-961.
38. Saynajakangas O, Keistinen T, Tuuponen T, Kivela SL. The course of childhood bronchiectasis: a case report and considerations of hospital use. Int J Circumpolar Health 1998;57:276-279.
39. King PT, Holdsworth SR, Freezer NJ, Villanueva E, Gallagher M, Holmes PW. Outcome in adult bronchiectasis. J Chronic Obstructive Pulm Dis 2005;2:27-34.
40. Khalid M, Saleemi S, Zeitouni M, Al DS, Khaliq MR. Effect of obstructive airway disease in patients with non-cystic fibrosis bronchiectasis. Ann Saudi Med 2004;24:284-287.
41. Hill SL, Burnett D, Hewetson KA, Stockley RA. The response of patients with purulent bronchiectasis to antibiotics for four months. Q J Med 1988;66:163-173.
42. AkalIn F, Koroglu TF, Bakac S, Dagli E. Effects of childhood bronchiectasis on cardiac functions. Pediatr Int 2003;45:169-174.
43. O'Leary CJ, Wilson CB, Hansell DM, Cole PJ, Wilson R, Jones PW. Relationship between psychological well-being and lung health status in patients with bronchiectasis. Respir Med 2002;96:686-692.
44. Simons L, Simons J, Friedlander Y, McCallum J. Chronic bronchitis and risk of coronary heart disease. Lancet 1996;348:1388-1389.
45. Kiechl S, Egger G, Mayr M, Wiedermann CJ, Bonora E, Oberhollenzer F, Muggeo M, et al. Chronic infections and the risk of carotid atherosclerosis: prospective results from a large population study. Circulation 2001;103:1064-1070.
46. Hill SL, Morrison HM, Burnett D, Stockley RA. Short term response of patients with bronchiectasis to treatment with amoxycillin given in standard or high doses orally or by inhalation. Thorax 1986;41:559-565.
47. Dogru D, Nik-Ain A, Kiper N, Gocmen A, Ozcelik U, Yalcin E, Asian AT. Bronchiectasis: the consequence of late diagnosis in chronic respiratory symptoms. J Trop Pediatr 2005;51:362-365.
48. Chang AB, Redding GJ. Bronchiectasis. In: Chernick V Boat TF, Wilmott RW, Bush A, editors. Kendig's disorders of the respiratory tract in children. Philadelphia: W.B. Saunders; 2006;463-477.
49. Morrissey BM, Evans SJ. Severe bronchiectasis. Clin Rev Allergy Immunol 2003;25:233-247.
50. Chang AB, Bilton D. Non-cystic fibrosis bronchiectasis exacerbations. Thorax 2008;63:269-276.
51. Laënnec RTH. De l'ausculatation médiate, un Traité du diagnostic des maladies des poumons et du coeur, fonde, principalement sur ce naveau moyen d'exploration. Paris, Brosson et Chande 1819.
52. Mannes, Priest, Nys. Preoperative lipiodol bronchography in bronchectasies. Acta Tuberc Belg 1951;42:67-72.
53. Westcott JL. Bronchiectasis. Radiol Clin North Am 1991;29:1031-1042.
54. Webb WR, Muller NL, Naidich DP. Airway diseases. High-resolution CT of the lung. Philadelphia: Lippincott, Williams & Wilkins; 2001.
55. Naidich DP, McCauley DI, Khouri NF, Stitik FP, Siegelman SS. Computed tomography of bronchiectasis. J Comput Assist Tomogr 1982;6:437-444.
56. Webb WR, Muller NL, Naidich DP. High-resolution computed tomography findings of lung disease. High-resolution CT of the lung. Philadelphia: Lippincott, Williams & Wilkins; 2001.
57. Silverman PM, Godwin JD. CT/bronchographic correlations in bronchiectasis. J Comput Assist Tomogr 1987;11:52-56.
58. Young K, Aspestrand F, Kolbenstvedt A. High resolution CT and bronchography in the assessment of bronchiectasis. Acta Radiol 1991;32:439-441.
59. Gaillard EA, Carty H, Heaf D, Smyth RL. Reversible bronchial dilatation in children: comparison of serial high-resolution computer tomography scans of the lungs. Eur J Radiol 2003;47:215-220.
60. Roberts CR, Pare PD. Composition changes in human tracheal cartilage in growth and aging, including changes in proteoglycan structure. Am J Physiol 1991;261:L92-101.
61. Rains JK, Bert JL, Roberts CR, Pare PD. Mechanical properties of human tracheal cartilage. J Appl Physiol 1992;72:219-225.
62. Matsuoka S, Uchiyama K, Shima H, Ueno N, Oish S, Nojiri Y. Bronchoarterial ratio and bronchial wall thickness on high-resolution CT in asymptomatic subjects: correlation with age and smoking. Am J Roentgenol 2003;180:513-518.
63. Brenner DJ. Estimating cancer risks from pediatric CT: going from the qualitative to the quantitative. Pediatr Radiol 2002;32:228-231.
64. Marchant JM, Masters IB, Taylor SM, Cox NC, Seymour GJ, Chang AB. Evaluation and outcome of young children with chronic cough. Chest 2006;129:1132-1141.
65. Marchant JM, Masters IB, Taylor SM, Chang AB. Utility of signs and symptoms of chronic cough in predicting specific cause in children. Thorax 2006;61:694-698.
66. Taussig LM, Smith SM, Blumenfeld R. Chronic bronchitis in childhood: what is it? Pediatrics 1981;67:1-5.
67. Seear M, Wensley D. Chronic cough and wheeze in children: do they all have asthma? Eur Respir J 1997;10:342-345.
68. Everard M. New respect for old conditions. Pediatr Pulmonol 2007;42:400-402.
69. Donnelly DE, Critchlow A, Everard ML. Outcomes in children treated for persistent bacterial bronchitis. Thorax 2007;62:80-84.
70. Agarwal G, Awasthi S, Kabra SK, Kaul A, Singhi S, Walter SD. Three day versus five day treatment with amoxicillin for non-severe pneumonia in young children: a multicentre randomised controlled trial. Br Med J 2004;328:791.
71. Jacobs B, Young NL, Dick PT, Ipp MM, Dutkowski R, Davies HD, Langley JM, et al. Canadian Acute Respiratory Illness and Flu Scale (CARIFS): development of a valid measure for childhood respiratory infections. J Clin Epidemiol 2000;53: 793-799.
72. Petsky HL, Acworth JA, Clark R, Winter D, Masters IB, Chang AB. Comparison of Canadian Acute Respiratory illness and flu scale (CARIFS) in children with asthma, recurrent cough and healthy controls. Respirology 2006;11:A25.
73. Darelid J, Lofgren S, Malmvall BE. Erythromycin treatment is beneficial for longstanding Moraxella catarrhalis associated cough in children. Scand J Infect Dis 1993;25:323-329.
74. Gottfarb P, Brauner A. Children with persistent cough - outcome with treatment and role of Moraxella catarrhalis? Scand J Infect Dis 1994;26:545-551.
75. McMillan CV, Honeyford RJ, Datta J, Madge NJ, Bradley C. The development of a new measure of quality of life for young people with diabetes mellitus: the ADDQoL-Teen. Health Qual Life Outcomes 2004;2:61.
76. Marchant JM, Morris P, Gaffney J, Chang AB. Antibiotics for prolonged moist cough in children. Cochrane Database Syst Rev 2005;4.
77. Stockley RA. Role of bacteria in the pathogenesis and progression of acute and chronic lung infection. Thorax 1998;53:58-62.
78. Grissell T, Chang AB, Gibson PG. Impaired toll-like receptor 4 and substance P gene expression is linked to airway bacterial colonisation in children. Pediatr Pulmonol 2007;42:380-385.
79. Brogden KA, Guthmiller JM, Salzet M, Zasloff M. The nervous system and innate immunity: the neuropeptide connection. Nat Immunol 2005;6:558-564.
80. Hard D, Latzin P, Hordijk P, Marcos V, Rudolph C, Woischnik M, Krauss-Etschmann S, et al. Cleavage of CXCR1 on neutrophils disables bacterial killing in cystic fibrosis lung disease. Nat Med 2007;13:1423-1430.
81. King P, Holdsworth S, Freezer N, Holmes P. Bronchiectasis. Int Med J 2006;36:729-737.
82. Watt AP, Brown V, Courtney J, Kelly M, Garske L, Elborn JS, Ennis M. Neutrophil apoptosis, proinflammatory mediators and cell counts in bronchiectasis. Thorax 2004;59:231-236.
83. Shields MD. Diagnosing chronic cough in children. Thorax 2006;61:647-648.
84. Cole PJ. Inflammation: a two edged sword. The model of bronchiectasis. Eur J Respir Dis Suppl 1986;147:6-15.
85. Phelan PD. Does adult chronic obstructive lung disease really begin in childhood? 92. Br J Dis Chest 1984;78:1-9.
86. Chang AB. State of the art: cough, cough receptors, and asthma in children. Pediatr Pulmonol 1999;28:59-70.
87. de Benedictis FM, Selvaggio D, de Benedictis D. Cough, wheezing and asthma in children: lesson from the past. Pediatr Allergy Immunol 2004;15:386-393.
88. van Asperen PP. Cough and asthma. Paediatr Respir Rev 2006;7:26-30.
89. Weinberger M, Abu-Hasan M. Pseudo-asthma: when cough, wheezing, and dyspnea are not asthma. Pediatrics 2007;120:855-864.
90. McKenzie S. Cough - but is it asthma? Arch Dis Child 1994;70:1-2.
91. National Asthma Council Australia. Asthma management Handbook, Melbourne, 2006/2007.
92. British Guideline on the management of asthma. Revised edition 2007. www.brit-thoracic.org.uk 2007.
93. National Heart LaBI. Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma. Full Report 2007. National Asthma Education and Prevention Program 2007.
94. Eastburn MM, Katelaris PH, Chang AB. Defining the relationship between gastroesophageal reflux and cough: probabilities, possibilities and limitations. Cough 2007;3:4.
95. Johnston NW, Sears MR. Asthma exacerbations. 1: epidemiology. Thorax 2006;61:722-728.
96. Didierlaurent A, Goulding J, Patel S, Snelgrove R, Low L, Bebien M, Lawrence T, et al. Sustained desensitization to bacterial Toll-like receptor ligands after resolution of respiratory influenza infection. J Exp Med 2008; Jan 28; Epub ahead of print.
97. Fayon M, Just J, Thien HV, Chiba T, Pascual L, Sandouk G, Grimfeld A. Bacterial flora of the lower respiratory tract in children with bronchial asthma. Acta Paediatr 1999;88:1216-1222.
98. Just J, Fayon M, Charavel A, Grimfeld A. Role of bacterial infections in children with asthma. Pediatr Pulmonol Suppl 1997;16:76.
99. Gaston B. Rethinking doctrine: bronchitis, eosinophils, and bronchoscopy in pediatric asthma. J Allergy Clin Immunol 2002;110:24-25.
100. Just J, Fournier L, Momas I, Zambetti C, Sahraoui F, Grimfeld A. Clinical significance of bronchoalveolar eosinophils in childhood asthma. J Allergy Clin Immunol 2002;110:42-44.
101. Graham V, Lasserson T, Rowe BH. Antibiotics for acute asthma. Cochrane Database Syst Rev 2001;3.
102. Chang AB, Faoagali J, Cox NC, Marchant JM, Dean B, Petsky HL, Masters IB. A bronchoscopic scoring system for airway secretions - airway cellularity and microbiological validation. Pediatr Pulmonol 2006;41:887-892.
103. Carter ER, Debley JS, Redding GR. Chronic productive cough in school children: prevalence and associations with asthma and environmental tobacco smoke exposure. Cough 2006;2:11.
104. Saito J, Harris WT, Gelfond J, Noah TL, Leigh MW, Johnson R, Davis SD. Physiologic, bronchoscopic, and bronchoalveolar lavage fluid findings in young children with recurrent wheeze and cough. Pediatr Pulmonol 2006;41:709-719.
105. Sahni R, Ammari A, Suri MS, Milisavljevic V, Ohira-Kist K, Wung JT, Polin RA. Is the new definition of bronchopulmonary dysplasia more useful? JPerinatol 2005;25:41-46.
106. Evans DJ, Bara AI, Greenstone M. Prolonged antibiotics for purulent bronchiectasis. Cochrane Database Syst Rev 2007;2.
107. Yang IA, Kim ST, Bell SC. Antibiotics in COPD, bronchiectasis and cystic fibrosis. In: Gibson PG, editor. Evidence based respiratory medicine. Malden, Mass.: Blackwell Pub; 2005;389-415.
108. Cymbala AA, Edmonds LC, Bauer MA, Jederlinic PJ, May JJ, Victory JM, Amsden GW. The disease-modifying effects of twice-weekly oral azithromycin in patients with bronchiectasis. Treat Respir Med 2005;4:117-122.
109. King P. Is there a role for inhaled corticosteroids and macrolide therapy in bronchiectasis? Drugs 2007;67:965-974.
110. Drobnic ME, Sune P, Montoro JB, Ferrer A, Orriols R. Inhaled tobramycin in non-cystic fibrosis patients with bronchiectasis and chronic bronchial infection with Pseudomonas aeruginosa. Ann Pharmacother 2005;39:39-44.
111. Scheinberg P, Shore E. A pilot study of the safety and efficacy of tobramycin solution for inhalation in patients with severe bronchiectasis. Chest 2005;127:1420-1426.
112. Cole PJ, Roberts DE, Davies SF, Knight RK. A simple oral antimicrobial regimen effective in severe chronic bronchial suppuration associated with culturable Haemophilus influenzae. J Antimicrob Chemother 1983;11:109-113.
113. Currie DC, Garbett ND, Chan KL, Higgs E, Todd H, Chadwick MV, Gaya H, et al. Double-blind randomized study of prolonged higher-dose oral amoxycillin in purulent bronchiectasis. Q J Med 1990;76:799-816.
114. Orriols R, Roig J, Ferrer J, Sampol G, Rosell A, Ferrer A, Vallano A. Inhaled antibiotic therapy in non-cystic fibrosis patients with bronchiectasis and chronic bronchial infection by Pseudomonas aeruginosa. Respir Med 1999;93:476-480.
115. Medical Council Research Prolonged anitbiotic treatment of severe bronchiectasis. Br Med J 1957; 255-259.
116. Kapur N, Chang A. Oral non steroid anti-inflammatories for children and adults with bronchiectasis. Cochrane Database Syst Rev 2007;4.
117. Llewellyn-Jones CG, Johnson MM, Mitchell JL, Pye A, Okafor VC, Hill SL, Stockley RA. In vivo study of indomethacin in bronchiectasis: effect on neutrophil function and lung secretion. Eur Respir J 1995;8:1479-1487.
118. Kopriva F, Sobolova L, Szotkowska J, Zapalka M. Treatment of chronic cough in children with montelukast, a leukotriene receptor antagonist. J Asthma 2004;41:715-720.
119. Crockett AJ, Cranston JM, Latimer KM, Alpers JH. Mucolytics for bronchiectasis. Cochrane Database Syst Rev 2001;1.
120. O'Donnell AE, Barker AF, Ilowite JS, Fick RB. Treatment of idiopathic bronchiectasis with aerosolized recombinant human DNase I. rhDNase Study Group. Chest 1998;113:1329-1334.
121. Jones AP, Rowe BH. Bronchopulmonary hygiene physical therapy for chronic obstructive pulmonary disease and bronchiectasis. Cochrane Database Syst Rev 1998;4.
122. Wills P, Greenstone M. Inhaled hyperosmolar agents for bronchiectasis. Cochrane Database Syst Rev 2006;2.
123. Kellett F, Redfern J, Niven RM. Evaluation of nebulised hypertonic saline (7%) as an adjunct to physiotherapy in patients with stable bronchiectasis. Respir Med 2005;99:27-31.
124. Chan TH, Ho SS, Lai CK, Cheung SW, Chan RC, Cheng AF, Chan CH. Comparison of oral ciprofloxacin and amoxycillin in treating infective exacerbations of bronchiectasis in Hong Kong. Chemotherapy 1996;42:150-156.
125. Tsang KW, Tan KC, Ho PL, Ooi GC, Ho JC, Mak J, Tipoe GL, et al. Inhaled fluticasone in bronchiectasis: a 12 month study. Thorax 2005;60:239-243.
126. Lasserson TJ, Holt K, Milan SJ, Greenstone M. Oral steroids for bronchiectasis (stable and acute exacerbations). Cochrane Database Syst Rev 2001;2.
127. Lasserson T, Holt K, Evans D, Greenstone M. Anticholinergic therapy for bronchiectasis. Cochrane Database Syst Rev 2001;2.
128. Franco F, Sheikh A, Greenstone M. Short acting beta-2 agonists for bronchiectasis. Cochrane Database Syst Rev 2003;1.
129. Sheikh A, Nolan D, Greenstone M. Long-acting beta-2-agonists for bronchiectasis. Cochrane Database Syst Rev 2001;4.
130. Corless JA, Warburton CJ. Leukotriene receptor antagonists for non-cystic fibrosis bronchiectasis. Cochrane Database Syst Rev 2000;2.
131. Bradley J, Moran F, Greenstone M. Physical training for bronchiectasis. Cochrane Database Syst Rev 2002;2.
132. Newall C, Stockley RA, Hill SL. Exercise training and inspiratory muscle training in patients with bronchiectasis. Thorax 2005;60:943-948.
133. Wedzicha JA, Muir JF. Noninvasive ventilation in chronic obstructive pulmonary disease, bronchiectasis and cystic fibrosis. Eur Respir J 2002;20:777-784.
134. Cranston JM, Crockett AJ, Moss JR, Alpers JH. Domiciliary oxygen for chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2005;4.
135. Corless JA, Warburton CJ. Surgery versus non-surgical treatment for bronchiectasis. Cochrane Database Syst Rev 2000;2.
136. Otgun I, Karnak I, Tanyel FC, Senocak ME, Buyukpamukcu N. Surgical treatment of bronchiectasis in children. J Pediatr Surg 2004;39:1532-1536.
137. Dupont M, Gacouin A, Lena H, Lavoue S, Brinchault G, Delaval P, Thomas R. Survival of patients with bronchiectasis after the first ICU stay for respiratory failure. Chest 2004;125:1815-1820.
138. Chang CC, Singleton RJ, Morris PS, Chang AB. Pneumococcal vaccines for children and adults with bronchiectasis. Cochrane Database Syst Rev 2007;2.
139. Chang CC, Morris PS, Chang AB. Influenza vaccine for children and adults with bronchiectasis. Cochrane Database Syst Rev 2007;3.
140. Maa SH, Tsou TS, Wang KY, Wang CH, Lin HC, Huang YH. Self-administered acupressure reduces the symptoms that limit daily activities in bronchiectasis patients: pilot study findings. J Clin Nurs 2007;16:794-804.
141. French J, Bilton D, Campbell F. Nurse specialist care for bronchiectasis. Cochrane Database Syst Rev 2003;1.